INDUCTIGRAFT

INDUCTIGRAFT osteoinductive bone graft substitute enables surgeons to provide a product with enhanced porosity and adaptability that today’s challenging orthopaedic surgeries require.

Enhanced image of porous Altapore product

Enhanced Bone Growth

With enhanced micro and macro porosity and ideal silicon content shown to be optimal for bone formation^2,3,4,5, INDUCTIGRAFT is designed to promote early vascularisation, increase cellular activity, and enhance bone growth as demonstrated in in-vitro and in-vivo pre-clinical studies.^1,2,3,*

^{*Preclinical data. Results may not correlate to performance in humans.}

Mechanism of Action

Learn more about how INDUCTIGRAFT works

Additional Product Benefits

Enhanced Performance

INDUCTIGRAFT achieves fusion rates on par with autograft—the gold standard in bone fusion. ^4,5,6,*

*Preclinical data. Results may not correlate to performance in humans.

Versatility and Ease of Use

The precise handling characteristics of INDUCTIGRAFT allow the product to be molded into multiple shapes to adapt to various surgical needs when using as standalone, with autograft, or bone marrow aspirate.¹

Enhanced Porosity

The interconnected and open porous structure of the silicate-substituted calcium phosphate phase of INDUCTIGRAFT is similar to human cancellous bone and is designed to promote enhanced bone growth.²

See References

INDUCTIGRAFT Instructions for Use January 2020.
Hing KA, Revell PA, Smith N, Buckland T. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds. Biomaterials. 2006 Oct;27(29):5014-26.
Campion CR, Chandler C, Buckland T, Hing K. Increasing strut porosity in silicate-substituted calcium-phosphate bone graft substitutes enhances osteogenesis. J Biomed Mater Res B Appl Biomater. 2011 May; 97(2):245-54.
Guth K, Campion C, Buckland T, Hing KA. Effect of silicate-substitution on attachment and early development of human osteoblast-like cells seeded on microporous hydroxyapatite discs. Adv Eng Mater. 2010;12(4): B77-B82.
Hing KA, Wilson LF, Buckland T. Comparative performance of three ceramic bone graft substitutes. Spine J. 2007; 7(4):475-490.
Fredericks DC, Petersen EB, Saihi N, Corley KGN, DeVries N, Grosland NM, Smucker JD. Evaluation of a novel silicate substituted hydroxyapatite bone graft substitute in a rabbit posterolateral fusion model. The Iowa Orthopaedic Journal. 2013;33:25-32.

Products

Programmes

Specialties